TACO pathophysiology
ISBT Education. Kapur R. Jun 6, 2018; 218861 Topic: Transfusion associated circulatory overload
Rick Kapur
Rick Kapur
This content is exclusively available for members.

You may become an ISBT member here.
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation, the participant will be able to:

- Recognize the risk factors for TACO development.
- Understand what is currently known about biomarkers in TACO.
- Understand that volume overload may not explain the whole TACO pathogenesis (possible contribution of inflammation or certain factors present in the transfusion product).
- That development of TACO animal models and further assessment and validation of potential biomarkers for TACO is highly needed in order to shed light on possible therapeutic interventions.


 
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies